1Gahbauer M, Keane P. Chronic cough: stepwise application in primary care practice of the ACCP guidelines for diagnosis and management of cough[J]. J Am Acad Nurse Pract, 2009,21 (8) :409-416.
3Lrwin RS, Madison JM. The diagnosis and treatment of cough [J]. N Engl J Med,2000,343(23):1715-1721.
4Fujimura M, Ogawa H, Nishizawa Y, et al. Comparison of atopic cough with cough variant asthma: is atopic cough a precursor of asthma? [J]. Thorax, 2003,58 (1): 14-18.
5Niimi Matsumoto H, Minakuchi M. Airway remodeling in cough variant asthma[J]. Lancet,2005,356(9229) :564-565.
6Eickelberg O, Roth M, Lorx R, et al. Ligand fndependent activation of the glueocorticoid receptor by beta-2 adrenergic receptor antagonists in primary human lung fibroblasts and vascular smooth muscle cells[J]. J Biol Mol Chem, 1999,274 (2) : 1005-1010.
7Fujimura M, Ohkura N, Abo M, et al. Exhaled nitric oxide levels in patients with atopic cough and cough variant asthma [J]. Respirology,2008,13(3) :359-364.
8Antoniu SA, Mihaescu T, Donner CF. Pharmacotherapy of cough variant asthma[J]. Expert Opin Pharmacother, 2007,8 (17) :3021 3028.
9Nishitsuji M, Fujimura M, Oribe Y, et al. Effect of montelukast in a guinea pig model of cough variant asthma [J]. Pulm Pharmaeol Ther, 2008,21 ( 1 ) : 142 145.
10Kawai S, Baba K, Matsubara A, et al. The efficacy of montelukast and airway mast cell profiles in patients with cough variant asthma[J]. J Asthma,2008,45(3) :243-250.
